Financials
- Market Capitalization 14.24 M
- Employee 24
- Founded 2017
- CEO N/A
- Website www.passagebio.com
- Headquarter Delaware, United States
- FIGI BBG00NBK4XF9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.66
売上高対価格比率
17.15
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4716 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.53 USD | -1.85% | -11.67% | -3.64% | -68.07% | 14.55 M USD | ||
| 4717 | TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | 0.00% | 0.00% | -21.60% | -59.00% | 14.51 M USD | ||
| 4729 | INAB IN8bio, Inc. - Common Stock | 1.38 USD | +2.99% | -1.43% | -4.83% | -17.37% | 13.59 M USD | ||
| 4733 | LNAI Lunai Bioworks Inc. - Common Stock | 2.98 USD | +5.30% | +8.76% | +12.03% | +92.26% | 13.51 M USD |